Skip to content
Research Article Open access CC BY 4.0

Perceived Benefits and Risk of NSAIDs in Relation to Its Association with Cancer: A Comprehensive Review

Jishu Kalita, Krishnanu Dutta, Saikat Sen, Biplab Kumar Dey, Pal Gogoi

Journal of Pharmaceutical Research International · pp. 236–244 · Published 12 Aug 2021

10.9734/jpri/2021/v33i40B32282

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are often used to treat fever and pain. Apart from its medicinal benefits, it is also well known for its numerous side effects, including myocardial infarction, gastrointestinal haemorrhage, renal failure, etc. Even beside these side effects NSAIDs are believed to play a major role in cancer. Though there are contrary of being inducing or preventive reason for cancer. Many studies shows NSAIDs are associated with the increasing risk of cancer. While as in various studies these drugs also have been investigated for their anti-cancer property as chronic inflammation has direct association with carcinogenesis. This review enlights the role of NSAIDs in cancer promotion and cancer prevention, connection between chronic inflammation and cancer, and some of the potentially lethal side effects of these drugs.

NSAID cancer COX-2 inhibitors chronic inflammation-associated cancer

Cited by 2

Development and evaluation of a Chinese herbal gel for analgesic and anti-inflammatory effects.

C. Yang, Wenting Zhong, Juan Du · Pakistan Journal of Pharmaceutical Sciences · 2023

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

15

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.